Company Overview

Butterfly Network, Inc. is a medical technology company operating in the healthcare diagnostics and medical imaging industries, with a primary focus on point-of-care ultrasound (POCUS). The company develops and commercializes portable, semiconductor-based ultrasound systems designed to make medical imaging more accessible, affordable, and scalable across clinical and non-clinical settings. Its core offering integrates proprietary hardware with cloud-based software, artificial intelligence tools, and subscription services.

The company’s principal revenue drivers include sales of its handheld ultrasound devices, recurring software subscriptions, and enterprise solutions for health systems, medical education institutions, and government or global health organizations. Butterfly Network serves hospitals, outpatient clinics, primary care providers, emergency medicine, medical schools, and resource-limited healthcare environments. Founded in 2011, the company was built around a novel ultrasound-on-a-chip technology and went public in 2021 through a merger with a special purpose acquisition company, evolving from a research-driven startup into a publicly traded medical device company.

Business Operations

Butterfly Network operates primarily through a single integrated business model encompassing portable ultrasound devices, software and cloud services, and AI-enabled imaging tools. The company generates revenue through device sales and recurring subscription plans that provide access to imaging software, data storage, workflow tools, and clinical decision support features. Its flagship products include the Butterfly iQ+ and Butterfly iQ3, which are handheld, whole-body ultrasound probes compatible with mobile devices.

Operations span both domestic and international markets, with the majority of revenue historically generated in the United States, alongside growing international sales. The company controls its core semiconductor-based ultrasound technology and software platform, while manufacturing is largely outsourced. Butterfly Network maintains relationships with academic medical centers, healthcare systems, non-profit organizations, and government entities to support clinical adoption, training, and global health initiatives.

Strategic Position & Investments

Butterfly Network’s strategy centers on expanding adoption of point-of-care ultrasound by lowering cost and complexity while increasing clinical utility through software and artificial intelligence. Growth initiatives focus on increasing subscription penetration, expanding enterprise and institutional deployments, and enhancing AI-driven automation and guidance features to support less experienced users. The company has emphasized software-driven recurring revenue as a long-term value driver.

The company has made targeted investments in product development and clinical validation rather than large-scale acquisitions. Its strategic priorities include advancing AI-based image interpretation, workflow automation, and tele-ultrasound capabilities. Butterfly Network also participates in global health and public-sector initiatives aimed at expanding access to diagnostic imaging in underserved regions, aligning its technology with emerging healthcare delivery models.

Geographic Footprint

Butterfly Network is headquartered in Burlington, Massachusetts, and operates primarily across North America, with additional commercial presence in Europe, Asia-Pacific, Latin America, and parts of Africa. Its products are marketed in dozens of countries, supported by a combination of direct sales, distributors, and strategic partners.

Internationally, the company’s influence is strongest in developed healthcare markets, while also maintaining a footprint in emerging and resource-limited regions through non-governmental organizations and public health programs. Although international revenue represents a smaller portion of total sales compared to the U.S., global expansion remains a stated component of the company’s long-term strategy.

Leadership & Governance

Butterfly Network was founded by Jonathan Rothberg, whose vision centered on democratizing medical imaging through semiconductor innovation. The company is governed by a board of directors with experience in healthcare, technology, and public markets, and management emphasizes innovation, clinical impact, and long-term adoption of ultrasound as a standard diagnostic tool.

Key members of the leadership team include:

• Joseph E. DeVivo – President and Chief Executive Officer
• Gregory Gibbons – Chief Financial Officer
• Heather Getz – Chief Legal Officer and Corporate Secretary
• Darius Shahinfar – Chief Commercial Officer
• Todd Fruchterman – Chief Technology Officer